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a b s t r a c t
The coherence between occupational exposure limits (OELs) and their corresponding biological limit val-
ues (BLVs) was evaluated for 2-propanol and acetone. A generic human PBPK model was used to predict
internal concentrations after inhalation exposure at the level of the OEL. The fraction of workers with pre-
dicted internal concentrations lower than the BLV, i.e. the ‘false negatives’, was taken as a measure for
incoherence. The impact of variability and uncertainty in input parameters was separated by means of
nested Monte Carlo simulation. Depending on the exposure scenario considered, the median fraction
of the population for which the limit values were incoherent ranged from 2% to 45%. Parameter impor-
tance analysis showed that body weight was the main factor contributing to interindividual variability
in blood and urine concentrations and that the metabolic parameters Vmax and Km were the most impor-
tant sources of uncertainty. This study demonstrates that the OELs and BLVs for 2-propanol and acetone
are not fully coherent, i.e. enforcement of BLVs may result in OELs being violated. In order to assess the
acceptability of this ‘‘incoherence’’, a maximum population fraction at risk of exceeding the OEL should be
speciﬁed as well as a minimum level of certainty in predicting this fraction.
 2014 Elsevier Inc. All rights reserved.
1. Introduction
Monitoring of workplace exposure to chemicals has become
common practice in many countries (Angerer et al., 2011). In this
context, occupational exposure limits (OELs) for air, such as thresh-
old limit values (TLVs), Maximale Arbeitzplatz-Konzentration wer-
ten (MAK-werten) and derived no effect limits for workers (DNEL
Worker), have been derived to control the health risk of chemical
exposure in occupational settings. Additionally, biological limit
values (BLVs) such as biological exposure indices (BEI) and Biolog-
ische Arbeitsstoff-Toleranzwerten (BAT) have been derived as ref-
erence values for biological media, such as blood and urine.
Another approach in which external dose-based guidance values,
such as the tolerable daily intake (TDI) or reference dose (RfD),
are translated into so-called biomonitoring equivalent (BE) values
is increasingly being used in the public health context, but so far
not in occupational settings (Hays et al., 2007, 2008).
Although BLVs are currently still limited in number (derived for
roughly 50 industrial chemicals), they strongly support and legiti-
mize the application of biological monitoring as a method to mea-
sure and control human exposure to chemical substances (Angerer
et al., 2007; Boogaard et al., 2011). Biological monitoring is embed-
ded in EU regulations DIR 80/1107/EEC, DIR 89/391/EEC and DIR
98/24/EC.
BLVs are typically derived from OELs, based on an empirical
relationship between external exposure levels and corresponding
internal concentrations (ACGIH, 2001; Angerer et al., 2011). In
these cases, enforcement of BLVs should guarantee that OELs are
not being exceeded since these OELs were originally derived from
experimental toxicological data (Thomas et al., 1996). A violation
of an OEL may remain unnoticed when the BLV is not being
exceeded at an exposure level that corresponds to the OEL. In the
present study, an OEL and its corresponding BLV are therefore
called coherent if the predicted internal concentration after expo-
sure to the OEL equals or exceeds the BLV. False negatives, i.e.
internal concentrations below the BLV after exposure at the level
of the OEL, should be avoided.
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In recent years, several physiologically based pharmacokinetic
(PBPK) models have been developed to support the derivation of
BLVs (Adams et al., 2005; Bartels et al., 2012; Leung, 1992; Tardif
et al., 2002; Truchon et al., 2013). However, coherence testing
between BLVs and OELswith PBPKmodels has only been performed
to a limited extent. Thomas et al. (1996) predicted the interindivid-
ual variability in the concentrations of chemicals in worker’s
exhaled breath and urine after exposure to OELs of 6 industrial
chemicals. They compared the results with the corresponding BLVs.
For the urinary metabolites of benzene, methyl chloroform and tri-
chloroethylene, they found that 54–97% of the worker population is
protected at the level of the BLV. However, Thomas et al. (1996)
only considered interindividual variability in input parameters,
and not uncertainty. It is important to distinguish these two sources
of variation since they have different implications for policy mak-
ers. Whereas interindividual variability indicates the population
fraction at risk and provides insight into the characteristics of sus-
ceptible individuals (Nestorov, 2001), uncertainty determines the
reliability of model predictions (Cullen, 1998; Morgan and
Henrion, 1990) and provides insight into the most efﬁcient ways
to improve model predictions, e.g. by more precise measurements
(Nestorov, 2001; Ragas et al., 2009).
The aim of the present study was to test the coherence between
the OELs and BLVs of two commonly used solvents, i.e. 2-propanol
and acetone. The BLVs of these substances were originally derived
from the OELs using linear regression between external and inter-
nal exposure levels. The PBPK model BioNormtox (Huizer et al.,
2012) was used here to predict blood and urine concentrations
after exposure to air concentrations at the level of the OEL. These
predicted internal concentrations were then compared to the cor-
responding BLVs, resulting in a measure of coherence. The impact
of uncertainty and interindividual variability was quantiﬁed sepa-
rately by means of nested Monte Carlo simulation.
2. Material and methods
2.1. BioNormtox model
2.1.1. Outline
We used the PBPK model BioNormtox, an extended version of
the IndusChemFate model as previously described by Huizer
et al. (2012), to assess the coherence between OELs and BLVs for
2-propanol and acetone. In the same publication, it was shown that
simulations for these substances were in line with experimental
human data. The model is brieﬂy described here; a more detailed
model description can be found in Huizer et al. (2012). The human
body is represented in BioNormtox by 10 main compartments: (1)
lung, (2) heart, (3) brain, (4) skin, (5) fat, (6) muscles, (7) bone, (8)
stomach and intestines, (9) liver and (10) kidney (Fig. 1). The lungs
are subdivided into bronchioles, mucosa, and alveolae to model the
washin–washout effect of solvent vapors in the respiratory tract,
following Mork et al. (2009) and Mork and Johanson (2006). Parti-
tioning between different compartments is based on a QSAR for tis-
sue:water partitioning, originally developed by Hendriks et al.
(2005). Metabolism (Michaelis–Menten kinetics) is based on the
metabolic parameters Vmax (maximum velocity of metabolism)
and Km (Michaelis–Menten constant).
2.1.2. Parameter uncertainty and variability
Variation in the model output was quantiﬁed as interindividual
variability and uncertainty separately, based on assigned parameter
distributions by Huizer et al. (2012). Interindividual variability for
resting conditions was described using literature-based distribu-
tions for all physiological parameters (Table 1). Lognormal distribu-
tions were used for continuous physiological parameters, whereas
fractional parameters were assigned betaPERT distributions.
Uncertainty distributions were derived for physico-chemical
parameters of 2-propanol and acetone (lognormal) and chemical
afﬁnity intercepts and exponents (betaPERT). The metabolic
parameters Km and Vmax were considered as variable and uncertain,
since variation in these parameter values may originate from both
interindividual variability (i.e., differences in enzymatic activity
between individuals) and uncertainty (i.e., differences in experi-
mental design and measurement uncertainty). For the present
study, all parameter distributions related to physico-chemical
properties and biotransformation of 2-propanol and acetone were
taken from Huizer et al. (2012) (Tables A-1 and A-2).
2.1.3. Model adjustments
In comparison to the original model, two major adjustments
were made: (1) renal excretion was now modeled as a process that
is described by the water soluble fraction of the substance in renal
blood and the production rate of urine, i.e. replacing the original
arbitrary cut-off value for glomerular ﬁltration (Eq. A-1), and (2)
the parameter distributions for human physiology were changed
to conditions that correspond to light work in order to simulate
more realistic workplace scenarios (see Section 2.2). A summary
of the parameter distributions for human physiology in rest and
at light work is presented in Table 1. The derivation of parameter
distributions for light work is described in more detail below.
2.2. Human physiology
Increased exercise may lead to changes in tissue perfusion and
ventilation characteristics. These changes originate from three
main physiological principles: (1) increase of cardiac output, (2)
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Fig. 1. Structure of the BioNormtox model. The continuous lines represent blood
ﬂows between tissues, whereas the dashed lines represent the exchange of the
parent compound or metabolites between the respiratory tract and the arterial
blood.
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increase of alveolar ventilation, and (3) change of distribution of
the cardiac output over tissues (Fiserova-Bergerova, 1983). Corre-
sponding parameter distributions for human physiology in the Bio-
Normtox model were adjusted to represent light work. In line with
Astrand (1983), we deﬁned light work as a workload of 35–50W.
This corresponds to daily scenarios for most occupational settings,
including work related to cleaning, construction, farming, indus-
trial processing, machine operating and painting (Ainsworth
et al., 2011).
2.2.1. Cardiac output and alveolar ventilation
Data from Astrand (1983) were used to derive a lognormal dis-
tribution that describes human variability of cardiac output during
light work. Similarly, a distribution for the description of variability
in alveolar ventilation was derived based on data by Astrand
(1983).
2.2.2. Fractional blood ﬂows
For the perfusion of tissues during light work, the parameter
distributions for fractional blood ﬂows (as fraction of the total car-
diac output) in rest were used as a starting point, since these dis-
tributions were well established based on a large number of
empirical data by Huizer et al. (2012). Deterministic multipliers
were used to convert these distributions from rest to light work
(Eq. (1)).
Eq. (1) – principle of scaling of fractional blood ﬂows to tissues
in rest to light work.
QCtissue light work ¼ QCtissue rest  Rtissue ð1Þ
where QCtissue light work is the fractional blood ﬂow to a tissue at light
exercise (% of cardiac output), QCtissue rest the fractional blood at rest
(% of cardiac output) and Rtissue the multiplier per tissue type
(dimensionless). The multipliers were calculated as the ratio
between typical values for fractional blood ﬂows to tissues at rest
and during light work. The mean values reported in Huizer et al.
(2012) were used as typical values at rest. Typical values during
light work were derived frommultiple data sources and then aggre-
gated per tissue type (Table A-3).
2.2.3. Other physiological parameters
The original distribution representing the volume of produced
urine was left unchanged as it includes data from individuals both
in rest and during light work (Raman et al., 2004). The fractional
transfer coefﬁcients for the washin–washout module in the model
were also left unchanged, since these are related to the alveolar
ventilation and are therefore scaled via this parameter (Mork
et al., 2009).
2.3. Coherence testing
The coherence between OELs and BLVs was determined by com-
paring the simulated blood or urine concentrations after inhalation
exposure at the level of the OEL for the deﬁned exposure duration
to the corresponding BLV of the parent chemical or its metabolite.
We calculated the fraction of ‘false negatives’ in the worker popu-
lation, i.e. the fraction of workers with predicted internal concen-
trations below the BLV after exposure to the OEL. These false
negatives indicate cases where a violation of the OEL does not nec-
essarily result in a violation of the BLV. The larger the fraction of
‘false negatives’, the less coherence is demonstrated.
Exposure to acetone and 2-propanol via inhalation was simu-
lated with the BioNormtox model for the following scenarios
(Table 2):
(1) A scenario of 8 h constant exposure to acetone at the OEL
(500 ppm in air) during light exercise, to test the coherence
with the BLV of acetone in urine.
(2) A scenario of 8 h constant exposure to 2-propanol at the OEL
(200 ppm in air) during light exercise, to test the coherence
with the BLVs of acetone in blood.
(3) A scenario of 8 h constant exposure to 2-propanol at the OEL
(200 ppm in air) during light exercise, to test the coherence
with the BLVs of acetone in urine.
Table 1
Variability distributions for physiological parameters in rest and during light work as used in the model simulations (see also Huizer et al., 2012 for further details).
Description of variable Units Distribution type At resta At light worka Multiplier (rest to exercise)
Alveolar ventilationb l/h Lognormal 511 (1.27) 1334 (1.14) Not applicable
Cardiac outputb l/h Lognormal 390 (1.24) 591 (1.11) Not applicable
Body weight kg Lognormal 71.4 (1.24) 71.4 (1.24)d Not applicable
Thickness of epidermis cm Lognormal 0.0084 (1.22) 0.0084 (1.22)d Not applicable
Thickness of stratum corneum cm Lognormal 0.0015 (1.37) 0.0015 (1.37)d Not applicable
Volume of produced urine l/h Lognormal 0.091 (1.51)c 0.091 (1.51)d Not applicable
Arterial fraction Unitless BetaPERT 0.251 (0.167,0.376) 0.251 (0.167,0.376)d Not applicable
Cardiac output fractions to tissues
Adipose tissue Unitless BetaPERT 0.061 (0.020,0.184) 0.104 (0.035,0.313) 1.7
Brain Unitless BetaPERT 0.117 (0.078,0.176) 0.07 (0.047,0.105) 0.6
Heart Unitless BetaPERT 0.056 (0.037,0.083) 0.056 (0.037,0.083) 1
Kidneys Unitless BetaPERT 0.177 (0.118,0.265) 0.088 (0.059,0.133) 0.5
Liver arterial Unitless BetaPERT 0.068 (0.046,0.103) 0.034 (0.023,0.051) 0.5
Liver venous Unitless BetaPERT 0.189 (0.126,0.283) 0.094 (0.063,0.141) 0.5
Lung Unitless BetaPERT 0.034 (0.023,0.051) 0.034 (0.023,0.051) 1
Muscle Unitless BetaPERT 0.142 (0.095,0.214) 0.313 (0.209, 0.470) 2.2
Skeleton (bone) Unitless BetaPERT 0.115 (0.077,0.173) 0.115 (0.077,0.173) 1
Skin Unitless BetaPERT 0.059 (0.039,0.089) 0.107 (0.071,0.160) 1.8
Fractional transfer coefﬁcients for washin–washout module of model
Mucosa to arterial blood Unitless Beta 25.26, 8.88 (0,1) 25.26, 8.88 (0,1)d Not applicable
Bronchioles to mucosa Unitless Beta 29.67, 3.67 (0,1) 29.67, 3.67 (0,1)d Not applicable
a Lognormal distributions are presented as geometric mean (geometric standard deviation), betaPERT distributions as most likely value (minimum, maximum), beta distri-
butions as alpha, beta (minimum, maximum).
b Alveolar ventilation and cardiac output were assumed to be correlated with a correlation coefﬁcient of 0.8 (Levitzky, 2003).
c Includes individuals from general population in all states of exercise, based on Raman et al. (2004).
d Unchanged at light work compared to situation in rest.
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(4) A scenario of 5 times 8 h exposure to 2-propanol at the OEL
(200 ppm in air) during light exercise, to test the coherence
with the BLV of 2-propanol in urine at the end of the work-
week (t = 104 h).
To account for the endogenous urinary level of acetone in the
general population, which is implicitly accounted for in the BLV,
the endogenous urinary concentration was added to the predicted
urinary concentration of acetone. This endogenous urinary concen-
tration was sampled from a lognormal distribution, based on liter-
ature data (Table A-5) (Ghittori et al., 1996; Kawai et al., 1992;
Pezzagno et al., 1986; Satoh et al., 1995; Wang et al., 1994;
Wigaeus et al., 1981).
2.4. Nested Monte Carlo simulation
Interindividual variability in physiological parameters and true
uncertainty in physico-chemical parameters were separated by
means of nested Monte Carlo simulation using Crystal Ball soft-
ware (Oracle, version 11). For each scenario in Table 2, a nested
Monte Carlo simulation was performed based on a randomly
selected set of 100 values from each of the variable parameters
and a randomly selected set of 100 values from each of the uncer-
tain parameters. In the analysis, the uncertain parameter sets
were ﬁxed one by one and the 100 variability values were iter-
ated, running the BioNormtox model after each iteration. This
process was repeated for each uncertainty set, resulting in 100
population distributions where each distribution reﬂects the
interindividual variability within a population. The results of the
simulations were then ranked, based on the median values of
the population distributions to reveal the variance between these
populations as a measure of uncertainty. Finally, the 10th, 50th
and 90th population distributions were plotted as cumulative
probability plots in which variability and uncertainty are both
represented.
2.5. Importance analysis
The relative contribution of the input parameters to the vari-
ability and uncertainty of the output parameters was calculated
by means of a modiﬁed Spearman rank correlation method as
described by Huizer et al. (2012). First, the correlation coefﬁcients
were recalculated to correct for correlation between the cardiac
output and alveolar ventilation by using partial Spearman rank
correlation coefﬁcients (Hamby, 1994). Second, the overall impor-
tance of parameters that were deﬁned as both variable and uncer-
tain, i.e. the metabolic parameters Vmax and Km, was separated into
an uncertainty and a variability component (Huizer et al., 2012).
The importance analysis was performed for each of the scenarios
in Table 2.
3. Results
3.1. Coherence between OELs and BLVs for acetone and 2-propanol
The cumulative probability plots in Fig. 2 display uncertainty
and variability in predicted concentrations of acetone in blood
and urine after inhalation exposure to acetone and 2-propanol in
accordance with the scenarios in Table 2. In each of these plots,
three curves are displayed, representing three of the 100 simulated
potential populations. They correspond with the 10th, 50th and
90th uncertainty percentiles of the simulation results for each
exposure scenario. Variance within one cumulative distribution,
reﬂected by the slope, represents interindividual variability within
the population. The variation between the cumulative distribu-
tions, reﬂecting different populations, represents uncertainty
(illustrated with the arrows in Fig. 2c). In the same ﬁgures, the
applicable BLV is depicted.
Coherence between the OEL and the corresponding BLV is dem-
onstrated when inhalation exposure at the level of the OEL does
not result in concentrations in blood or urine below the BLV. The
level of coherence was speciﬁed by quantiﬁcation of the predicted
fraction of ‘false negatives’, i.e. individuals with predicted internal
concentrations below the BLV after exposure to the OEL, in the
worker population (variability) and the corresponding probability
level of this prediction (uncertainty). Fig. 2 shows that there is a
50% chance that the fraction of false negatives is 2% of the popula-
tion in comparison with the American BLV (BEI) for acetone in
urine, whereas there is 10% chance that this fraction is 10%. In case
the German BLV (BAT) for the same scenario is considered, there is
a 50% chance that population fraction of false negatives is 45%,
whereas there is 10% chance that this is as much as 75%.
In Table 3 the coherence between the OELs and the BLVs for ace-
tone and 2-propanol is presented for each simulated scenario. This
coherence is expressed as the predicted fraction of false negatives
in the worker population for three different probability levels (i.e.,
the 10th, 50th and 90th percentile). Table 3 shows that the median
fraction of false negatives in the worker population ranges from 2%
to 45% over the four different scenarios. The 10th percentile of the
false negatives in the worker population ranges from 10% to 93%,
while the 90th percentile ranges from 0% to 20%. The largest uncer-
tainty in the calculated fraction is found for 2-propanol in the end
of workweek scenario.
3.2. Parameter importance
Fig. 3 shows the results of the parameter importance analysis.
For all scenarios, variability plays a major role in the variation in
blood and urine concentrations (60–80% of the total variation),
mainly as a result of the human physiological parameters body
weight and alveolar ventilation. Uncertainty and variability in the
metabolic parameters Vmax and Km are also an important source
Table 2
Occupational exposure limits (OELs) and Biological limit values (BLVs) for acetone and 2-propanol.
Occupational exposure limit Biological limit value
Parent compound in working atmosphere Acetone in blood Acetone in urine
(ppm) Time (h)* Reference (mg/l) Time (h) Reference (mg/l) Time (h) Reference
Acetone 500** 8 MAK (1993) – – – 80 8 BAT (1995)
TLV (1996) – – – 50 8 BEI (1999)
2-Propanol 200*** 8 MAK (1996) 25 8 BAT, 2009 25 8 BAT (2009)
TLV (2003) – – – 40 5  8 BEI (2006)
* From onset of exposure (t = 0 h).
** 1188 mg/m3 acetone.
*** 490 mg/m3 2-propanol.
4 D. Huizer et al. / Regulatory Toxicology and Pharmacology xxx (2014) xxx–xxx
Please cite this article in press as: Huizer, D., et al. Testing the coherence between occupational exposure limits for inhalation and their biological limit
values with a generalized PBPK-model: The case of 2-propanol and acetone. Regul. Toxicol. Pharmacol. (2014), http://dx.doi.org/10.1016/
j.yrtph.2014.05.004
of variation (10–30% of the total variation), in particular for the 2-
propanol scenarios. Other parameters that have a relatively large
inﬂuence on the simulated blood and urine concentrations are
parameters that are related to the QSAR for tissue partitioning,
expressed as Ktw (lipid, protein and water fractions of tissues and
their corresponding afﬁnity exponents and intercepts) and Kow.
4. Discussion
First, model parameterizations and assumptions that may have
inﬂuenced the results are discussed. Next, the coherence between
the OELs and BLVs for 2-propanol and acetone is discussed. Finally,
possible implications for policy makers are outlined.
4.1. Inﬂuence of parameterization and assumptions
To support the comparison between OELs and BLVs, the major-
ity of the model parameters related to human physiology was
scaled from rest to light work. As the availability of empirical
human physiological data on fractional blood ﬂows to tissues dur-
ing light work was limited, the parameters distributions estab-
lished for rest conditions were extrapolated to light work, using
so called multipliers. This way, the robustness of the parameteriza-
tion in rest as derived by Huizer et al. (2012) was maintained.
However, the absence of detailed information about tissue lumping
(i.e., the aggregation of similar tissues into groups) in multiple lit-
erature sources (Table A-3), as well as the lack of a speciﬁc deﬁni-
tion of ‘light work’ may have inﬂuenced the ﬁnal parameterization
of the model. However, a comparison with data from Fiserova-
Bergerova (1983) (Table A-4) indicates that the reported blood
ﬂows to relevant organs, such as the muscles, kidneys and liver,
during light work are in line with the parameterization of the
BioNormtox model.
Additional model simulations (Figs. 4 and A-1) show that the
scaling of physiological parameters from rest to light work has a
signiﬁcant inﬂuence on the predicted blood and urine concentration
Table 3
Predicted fraction of false negatives in the working population, i.e. workers with predicted internal concentrations lower than the biological limit value after inhalation exposure
at the level of the OEL, as a measure of incoherence between limit values for acetone and 2-propanol as simulated with the BioNormtox model in four exposure scenarios.
Exposure scenario Biological limit value Predicted population fraction of false negatives
(incoherence) in % (median value
with p10–p90 uncertainty range)
No. External Internal
1 Acetone (500 ppm – 8 h) Acetone in urine (end-of-workday) BAT (D): 80 mg/l 45% (20–75)
BEI (US): 50 mg/l 2% (0–10)
2 2-Propanol (200 ppm – 8 h) Acetone in blood (end-of-workday) BAT (D): 25 mg/l 5% (2–32)
3 2-Propanol (200 ppm – 8 h) Acetone in urine (end-of workday) BAT (D): 25 mg/l 28% (8–67)
4 2-Propanol (200 ppm – 5  8 h) Acetone in urine (end-of-workweek) BEI (US): 40 mg/l 17% (0–93)
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Fig. 2. Cumulative probability plots of the simulated median (continuous line), 10th and 90th (dotted lines) concentration percentiles in blood and urine after inhalation of
acetone (2a) and 2-propanol (2b, c, d) at the level of the OEL for 8 h during light exercise. Corresponding BLVs for each scenario are also displayed.
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of acetone; the internal concentrations decrease with decreasing
exercise levels. Mork and Johanson (2006) reported similar
results for acetone based on experimental human data and model
simulations. Schaller and Triebig (2002) also report an increase of
the acetone concentration in urine with increasing activity. These
results illustrate that the level of physical exercise signiﬁcantly
inﬂuences the relationship between external and internal exposure
concentrations. For our exposure scenarios, we would have found
lower coherence levels at lower exercise levels. To put it in another
way: at lower exercise levels there is a higher risk of the OEL being
exceeded while the BLV is not being exceeded.
Another factor that may have inﬂuenced the model predictions
is the parameterization of renal excretion. Urinary excretion in
PBPK models for 2-propanol and acetone has generally been
parameterized as a ﬁrst-order process (Clewell et al., 2001) or
based on partitioning (Kumagai and Matsunaga, 1995). Mork and
Johanson (2006) neglected this route entirely in their acetone
model, stating that urinary excretion is not a signiﬁcant elimina-
tion route for this substance. In our model renal excretion depends
on the water soluble fraction of the substance in renal blood and
the production rate of urine, replacing the arbitrary cut-off value
for glomerular ﬁltration in the Huizer et al. (2012) model. This
modiﬁcation also allowed a probabilistic approach of the urinary
excretion through the derived parameter distributions involved.
This results in urinary excretion levels around 1% of the total dose
for both 2-propanol and acetone, which is in line with the pub-
lished models and the background documentation of the BLVs
(ACGIH, 2001; DFG, 2012).
Finally, possible covariation between metabolic parameters
Vmax and Km was not considered in our analyses, due to a lack of
quantitative information on the exact correlation between these
two parameters. However, as covariation is expected to be relevant
mainly for the variability components of Vmax and Km, based on
interindividual variation in the activity of metabolic enzymes
(Dorne et al., 2004; Martinez et al., 2010), and the importance of
uncertainty was considerably higher in comparison with interindi-
vidual variability for these parameters in our analyses, it is
expected that ignoring the possible covariation has inﬂuenced
the results only to a limited extend.
4.2. Coherence between exposure limits for 2-propanol and acetone
In this study, four different exposure scenarios were assessed.
These scenarios include variation in exposure concentration, expo-
sure duration, type of biological medium (blood and urine) and
metabolic phase (parent and ﬁrst metabolite).
Based on our coherence test, we found that the BLVs for
2-propanol and acetone are likely (i.e., with 50% certainty) to be
coherent with their OEL for the majority of the working population
(55–98%). Our results are comparable to those of Thomas et al.
(1996), who predicted´ protected population´ fractions ranging from
54% to 97% after exposure to benzene, methyl chloroform and
trichloroethylene. However, Thomas et al. (1996) only included
interindividual variability in input parameters, and not uncer-
tainty. Our approach has the advantage that the probability of
the predictions can also be speciﬁed.
For a further interpretation of our results, it is important to
understand the scientiﬁc basis underlying the BLVs, i.e. the BAT
and BEI values for acetone and 2-propanol. German BAT values
are limit values which should not be exceeded, while the BEI values
are advisory levels that may be exceeded by a fraction of the pop-
ulation. However, this is in most cases not explicitly deﬁned
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Fig. 3. Parameter importance analysis of the simulated scenarios for acetone (3a) and 2-propanol (3b, c, d). For every scenario the contribution of variability and uncertainty
to the total variation is presented per parameter.
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(Morgan and Schaller, 1999). In the case of acetone and 2-propanol,
both the BEI and BAT values have been established based on a rela-
tionship between external (inhalation) and internal (urine) expo-
sure. Nevertheless, the BLVs differ substantially, i.e. 50 for the
BEI vs. 80 mg/l urine for the BAT. This is most likely a result of dif-
ferences in the interpretation of the assessed (exposure) data, as is
illustrated in the background documentation of the BAT for ace-
tone in which a range of potential limit values from 50 to 80 mg/
l urine is suggested. As a consequence of the arbitrary choice for
80 mg/l as a suitable BAT value, our results show a lower coherence
level for this BAT value than for the BEI value.
The results of the parameter importance analyses provide
insight into the main factors contributing to the variability and
uncertainty in the model predictions. The physiological parameters
body weight and alveolar ventilation and the metabolic parame-
ters Vmax and Km turn out to be the most important sources of var-
iation. Body weight is by far the most dominant parameter, as the
volume of all model compartments is related to body weight. Inter-
nal concentrations tend to decrease with increasing body weight,
implying that for individuals with a large body weight there is a
higher chance of incoherence between the OEL and the BLV. The
Vmax for acetone is an important source of uncertainty, pointing
towards acetone metabolism as an important elimination route.
Partitioning parameters become more important in scenarios in
which urinary concentrations are predicted, which can be
explained by the fact that only the dissolved fraction of acetone
in blood is being excreted into urine.
4.3. Practical implications
The present study shows that OELs and BLVs of 2-propanol and
acetone are not fully coherent, i.e. enforcement of BLVs does not
always guarantee that OELs are being met. These OELs were origi-
nally derived from toxicity data and are therefore more directly
linked to possible adverse health effects than BLVs. However, it
should be stressed that incoherence does not necessarily imply
adverse health effects. It is generally acknowledged that internal
exposure is a better dose metric for toxicity than external exposure
because the dose at the receptor site is an important driver of tox-
icity. Assuming equal receptor sensitivity, the value of the NOEL
will mainly be determined by those individuals that reach rela-
tively high internal concentrations under similar external exposure
conditions. In our case, this would typically be the lightweight peo-
ple with a high exercise level. Our study showed that heavy people
with a low level of exercise have the highest risk of incoherence.
This indicates that sensitivity is inversely related to incoherence,
i.e. individuals with a high risk of incoherence (i.e., heavy persons
with a low exercise level) will be sufﬁciently protected at the level
of the OEL. Reasoning along these lines, a coherence level of 50%
would provide sufﬁcient protection for the entire population.
The deﬁnition of coherence that we used in our case study is
applicable only to cases where the OEL is derived from toxicity
data and the BLV is subsequently derived from the OEL, e.g., based
on an empirical relationship between external and internal con-
centrations. This deﬁnition of coherence changes if the BLV would
be established directly based on toxicity data and the OEL would
subsequently be derived from the BLV. In that case, the OEL and
BLV are coherent only if the BLV is not being exceeded at the expo-
sure level that corresponds to the OEL. In the context of risk assess-
ment, coherence testing based on experimentally derived BLVs is
preferred over BLVs that are derived from OELs based on the
empirical relationship between external and internal concentra-
tions. However, in practice data limitations may constrain this
approach.
The large impact of exercise levels on the coherence of OELs and
BLVs shows that OELs should not only consist of a concentration
limit, but also include a speciﬁcation of the exercise level for which
it applies. Although it is generally recognized that the exercise lev-
els inﬂuence internal concentrations, e.g. Astrand (1983) and Safe
Work Australia (2012), speciﬁcations of exercise levels are typi-
cally limited to broad classiﬁcations such as ‘‘light work’’, ‘‘moder-
ate work’’ and ‘‘heavy work’’! A more detailed speciﬁcation of these
reference exercise levels for occupational exposure standards will
support the safe application of OELs and BLVs under varying work-
ing conditions.
Our results show that uncertainty in the predicted concentra-
tions is mainly caused by uncertainty in metabolic parameters
(i.e. Vmax and Km of 2-propanol and acetone) and partitioning
parameters (i.e. Ktw). If uncertainty is to be reduced, research
should focus on a more accurate determination of these metabolic
and partitioning parameters. However, the ﬁrst step is to deter-
mine whether reduction of uncertainty – and thus additional
research – is desirable or necessary. This requires the speciﬁcation
of a minimum level of certainty for the predicted coherence level of
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Fig. 4. Cumulative probability plots of the simulated median (continuous line), 10th and 90th (dotted lines) concentration percentiles in urine after inhalation of acetone at
the level of the OEL for 8 h in rest and during light exercise. Corresponding BLVs for this scenario are also displayed.
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the worker population, e.g. a 90% probability level that the limit
values are coherent for 50% of the worker population. In the pres-
ent situation in which BLVs are based on experimentally derived
OELs, regulatory authorities have two options if a coherence test
shows that the combined levels of certainty and coherence level
cannot be realized, i.e. either lower the BLV until sufﬁcient coher-
ence is realized or initiate new research to reduce uncertainty.
A major step forward in the reduction of incoherence would be
the derivation of BLVs with PBPK modeling, analogous to the BE
approach of Hays et al. (2008), in which the maximum allowed
population fraction at risk and the level of certainty is deﬁned
upfront.
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